Efficacy and Safety of Vasopressin and Terlipressin in Preterm Neonates: A Systematic Review.

Abdulrahman Salim Alsaadi Katelyn Sushko Vivian BuiJohn van den AnkerAbdul Razack Samira Samiee-Zafarghandy

Published in: International journal of environmental research and public health (2022)

AVP and terlipressin may improve measured blood pressure values and possibly end-organ perfusion among neonates with refractory hypotension. However, the efficacy-safety balance of these drugs should be assessed on an individual basis and as per the underlying cause. Studies on the optimal dosing, efficacy, and safety of AVP and terlipressin in preterm neonates with variable underlying conditions are critically needed.

Keyphrases

low birth weight
preterm infants
preterm birth
blood pressure
gestational age
adipose tissue
type diabetes
case control
drug induced
glycemic control